TRI-LEVLEN 28 Rx
Generic Name and Formulations:
Levonorgestrel 0.05mg, ethinyl estradiol 30micrograms (6 tabs); levonorgestrel 0.075mg, ethinyl estradiol 40micrograms (5 tabs); levonorgestrel 0.125mg, ethinyl estradiol 30micrograms (10 tabs); inert (7 tabs).
Indications for TRI-LEVLEN 28:
Tri-Levlen 28: 1 tab daily for 28 days; repeat. Tri-Levlen 21: 1 tab daily for 21 days, then 7 tablet-free days; repeat.
Progestin + estrogen.
Thrombophlebitis or thromboembolic disorders. Cerebral vascular or coronary artery disease. Breast or other estrogen-dependent neoplasms. Undiagnosed abnormal genital bleeding. Cholestatic jaundice of pregnancy or jaundice with prior OC use. Hepatic adenoma or carcinoma. Pregnancy (Cat.X).
Smokers over 35 years of age: not recommended. Uncontrolled hypertension. Hypertriglyceridemia. Discontinue if jaundice, visual disturbances, migraine or other severe headaches occur. Do regular complete physical exams. May need barrier contraception with Sunday starts or postpartum use (see literature). Nursing mothers: not recommended.
Antagonized by hepatic enzyme inducing drugs (eg, rifampin, griseofulvin, St. John's wort), possibly others. May affect measurement of sex hormone-binding globulin levels.
Hypertension, nausea, vomiting, breakthrough bleeding, amenorrhea, transient delay of ovulation after discontinuation, edema, chloasma, mastodynia, headache, intolerance to contact lenses. Increased risk of gallbladder disease, thromboembolic disorders.
- Digoxin Ups Risk of Death in A-Fib, CHF Patients in Largest Study to Date
- Mylan Launches Generic Seasonale
- New Strategies to Treat Depression in Youth Using SSRIs
- Relaxation Response Improves IBS, IBD Symptoms in First-of-Kind Study
- Arginase-Inhibiting Drugs May Be Future Tx for Obesity-Related Hypertension